Yoshinori Marunaka Selected Research

Hyperglycemia

1/2023	Mumefural prevents insulin resistance and amyloid-beta accumulation in the brain by improving lowered interstitial fluid pH in type 2 diabetes mellitus.
1/2023	Therapeutic potential of multifunctional myricetin for treatment of type 2 diabetes mellitus.
1/2019	Targeting acidity in cancer and diabetes.
1/2018	Improvement of Diabetes Mellitus Symptoms by Intake of Ninjin'yoeito.
1/2016	Sodium-chloride Difference and Metabolic Syndrome: A Population-based Large-scale Cohort Study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yoshinori Marunaka Research Topics

Disease

23	Neoplasms (Cancer) 09/2022 - 12/2006
12	Stomach Neoplasms (Stomach Cancer) 01/2021 - 12/2006
11	Insulin Resistance 01/2023 - 03/2013
9	Esophageal Squamous Cell Carcinoma 01/2021 - 01/2014
6	Diabetes Mellitus 10/2021 - 01/2014
5	Hyperglycemia 01/2023 - 01/2016
5	Type 2 Diabetes Mellitus (MODY) 01/2023 - 02/2014
4	Carcinogenesis 05/2021 - 09/2014
4	Hypertension (High Blood Pressure) 01/2016 - 03/2004
4	Lung Injury 10/2008 - 01/2007
3	Acidosis 01/2019 - 03/2013
3	Pheochromocytoma 01/2017 - 08/2007
3	Ascites 01/2014 - 12/2006
3	Lung Diseases (Lung Disease) 03/2009 - 05/2006
3	Acute Lung Injury 10/2008 - 02/2005
2	Obesity 01/2023 - 01/2023
2	Esophageal Neoplasms (Esophageal Cancer) 01/2021 - 02/2018
2	Virus Diseases (Viral Diseases) 01/2018 - 01/2014
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2009 - 12/2006
2	Hypoxia (Hypoxemia) 04/2007 - 06/2006
2	Hyperoxia 04/2007 - 01/2007
2	Edema (Dropsy) 12/2006 - 02/2005
2	Body Weight (Weight, Body) 03/2006 - 05/2002
1	Frailty 01/2024
1	Alzheimer Disease (Alzheimer's Disease) 01/2023
1	Hematuria 12/2022
1	Lung Neoplasms (Lung Cancer) 09/2022
1	Cognitive Dysfunction 01/2022
1	Cerebral Small Vessel Diseases 01/2022
1	Cardiovascular Diseases (Cardiovascular Disease) 08/2021
1	Basal Cell Carcinoma (Rodent Ulcer) 11/2019
1	Carcinoma (Carcinomatosis) 01/2019
1	Non-alcoholic Fatty Liver Disease 01/2018

Drug/Important Bio-Agent (IBA)

7	Insulin (Novolin)FDA Link 01/2023 - 05/2002
6	AcidsIBA 01/2023 - 11/2013
6	BuffersIBA 01/2019 - 01/2014
6	ChloridesIBA 06/2014 - 02/2008
5	Proteins (Proteins, Gene)FDA Link 10/2019 - 03/2006
5	Glucose (Dextrose)FDA LinkGeneric 01/2019 - 05/2002
5	SaltsIBA 10/2018 - 03/2004
4	AnionsIBA 01/2021 - 04/2007
4	Oxygen (Dioxygen)IBA 01/2019 - 02/2005
4	SolutionsIBA 05/2017 - 08/2012
3	QuercetinIBA 01/2023 - 03/2004
3	FlavonoidsIBA 01/2023 - 03/2004
3	Carbonic Anhydrases (Carbonic Anhydrase)IBA 10/2021 - 09/2014
3	Adenosine Triphosphatases (ATPase)IBA 01/2021 - 09/2014
3	Sodium-Hydrogen ExchangersIBA 01/2021 - 01/2012
3	Lactic Acid (Lactate)FDA LinkGeneric 11/2019 - 01/2019
3	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2018 - 04/2007
3	RNA (Ribonucleic Acid)IBA 07/2016 - 03/2006
3	Expectorants (Mucolytics)IBA 03/2009 - 05/2006
3	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 10/2008 - 04/2007
3	Nitric Oxide (Nitrogen Monoxide)FDA Link 10/2008 - 04/2007
3	Messenger RNA (mRNA)IBA 10/2007 - 03/2004
2	ninjin'yoeitoIBA 01/2024 - 01/2018
2	myricetinIBA 01/2023 - 01/2014
2	Antihypertensive Agents (Antihypertensives)IBA 01/2023 - 03/2004
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 10/2019
2	Superoxide DismutaseIBA 05/2021 - 04/2007
2	NADPH Oxidases (NAD(P)H oxidase)IBA 05/2021 - 01/2018
2	Aquaporins (Water Channels)IBA 01/2021 - 01/2016
2	Ion Channels (Ion Channel)IBA 01/2021 - 09/2014
2	Proton Pump InhibitorsIBA 11/2020 - 01/2019
2	Small Interfering RNA (siRNA)IBA 11/2019 - 10/2019
2	Adenosine Triphosphate (ATP)IBA 10/2018 - 06/2006
2	Protein Isoforms (Isoforms)IBA 01/2018 - 08/2007
2	Propolis (Bee Bread)IBA 05/2015 - 03/2013
2	K Cl- CotransportersIBA 01/2014 - 11/2013
2	Nerve Growth Factor (NGF)IBA 01/2012 - 08/2007
2	Furosemide (Lasix)FDA LinkGeneric 08/2011 - 12/2006
2	Cisplatin (Platino)FDA LinkGeneric 12/2009 - 12/2006
2	Ambroxol (Mucosolvan)IBA 03/2009 - 05/2006
2	7- chloro- 3- imino- 5- methyl- 2- azabicyclo(4.1.0)heptaneIBA 10/2008 - 04/2007
2	CytokinesIBA 04/2007 - 01/2007
1	mumefuralIBA 01/2023
1	Glucagon-Like Peptide-1 ReceptorIBA 01/2023
1	Amyloid (Amyloid Fibrils)IBA 01/2023
1	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 01/2023
1	Amyloid beta-PeptidesIBA 01/2023
1	Catechin (Z 7300)IBA 01/2023
1	Triglycerides (Triacylglycerol)IBA 01/2023
1	Indicators and Reagents (Reagents)IBA 12/2022
1	Keratin-19 (Keratin 19)IBA 09/2022
1	antigen CYFRA21.1IBA 09/2022
1	AdrenomedullinIBA 01/2022
1	CateninsIBA 11/2019
1	sodium-iodide symporter (sodium iodide symporter)IBA 01/2019
1	NF-kappa B (NF-kB)IBA 01/2019
1	Metformin (Glucophage)FDA LinkGeneric 01/2019
1	carboxyl radical (COO-)IBA 10/2018
1	Aquaporin 1IBA 07/2018
1	Death Domain ReceptorsIBA 07/2018
1	Chloride-Bicarbonate AntiportersIBA 05/2018
1	rat CLIC1 proteinIBA 05/2018
1	Membrane Proteins (Integral Membrane Proteins)IBA 02/2018
1	tranilastIBA 02/2018

Therapy/Procedure

10	Therapeutics 01/2023 - 04/2007
7	Esophagectomy 10/2019 - 06/2014
1	Diet Therapy (Therapy, Diet) 01/2023